Markets.com Logo

BIOSK

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2.5256$
  • Previous Close
    2.4237$
  • 52 Week Change
    2.20$
  • Day Range
    0.10$
  • 52 Week High/Low
    1.1$ - 3.3$
  • Dividend Per Share
    0
  • Market cap
    43 301 K$
  • EPS
    -0.02
  • Beta
    0.353
  • Volume
    --

About

BIOSK.AT refers to the stock of BiOSiLK Therapeutics AG, traded on the Vienna Stock Exchange. It's an Austrian company focused on the development of innovative therapies in the fields of dermatology and wound healing, utilizing silk fibroin technology. This symbol allows investors to easily identify and trade shares of BiOSiLK Therapeutics AG within the Austrian market.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Company Performance: Strong revenue growth, profitability, and successful clinical trial outcomes typically drive the stock price higher. Conversely, poor financial results or trial failures can lead to price declines.

Industry Trends: Positive developments in the biotechnology sector, such as new drug approvals or advancements in cancer research, can boost investor confidence and increase demand for BIOSK.AT shares.

Regulatory Environment: Changes in regulations regarding drug approvals, pricing, or healthcare policies can significantly impact the company's future prospects and consequently affect the stock price.

Market Sentiment: Overall investor confidence and risk appetite play a crucial role. A bullish market environment tends to support higher stock prices, while a bearish market can depress them.

Competition: The emergence of new competitors or the success of competing products can erode BIOSK.AT's market share and negatively affect its stock price.

Economic Conditions: Broader economic factors such as interest rates, inflation, and economic growth can influence investor sentiment and affect the valuation of BIOSK.AT.

News & Events: Announcements related to partnerships, acquisitions, or significant scientific breakthroughs can trigger substantial price movements in BIOSK.AT stock.

Specific Drug Pipeline: Positive or negative results from clinical trials for key drugs in BIOSK.AT's pipeline will significantly move the stock.

Management Team: Changes in the leadership team or perceptions of the management's competence can influence investor confidence.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--